prader willi syndrome glp 1 Low dose systemic AAV-exendin-4 gene therapy for Prader-Willi and dietary obesity Prader–Willi syndrome - Wikipedia

But allergic reaction to Januvia has been reported since the drug became available on the market

Off-Label Promotion and Ethical Implications The aggressive marketing strategies employed to promote GLP-1 agonists for weight loss prior to obtaining formal regulatory approval for such indications raise significant ethical and legal questions

Prescription medications cost $9001,700/month without insurance

How to Get Started With GLP-1 Weight Loss Medications: Next Steps for Patients Individuals researching GLP-1 weight loss medications often want clear guidance on how to begin evaluating their options

Based on publicly available information, those states are: Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, and Wisconsin